Abstract
A weak increase in malformation risk may exist after use of gonatotropin releasing hormones but this may be a result of subfertility. No teratogenic effect of drugs used at diabetes insipidus is seen but the number of exposures studied is low.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Källén B, Carlsson SS, Bengtsson BKA. Diabetes insipidus and use of desmopressin (Minirin®) during pregnancy. Eur J Endocrinol. 1995;132:144–6.
Linder N, Maloth I, Ohel G, Yourish D, Tamir I. L-Deamino-8-d-arginine treatment in pregnancy and neonatal outcome. Am J Perinatol. 1986;3:165–7.
Ray JG. DDAVP use during pregnancy: an analysis on the safety for mother and child. Obstet Gynecol Surv. 1998;33:450–5.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Källén, B. (2019). Maternal Use of Hypophyseal or Hypothalamic Hormones and Infant Congenital Malformations. In: Maternal Drug Use and Infant Congenital Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-17898-7_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-17898-7_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-17897-0
Online ISBN: 978-3-030-17898-7
eBook Packages: MedicineMedicine (R0)